Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-24-002788

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 10, 2024 55.69M sh
Current Liabilities Q1 2024 · Mar 31, 2024 $5.34M
Current Liabilities Q1 2024 · Dec 31, 2023 $4.81M
Total Liabilities Q1 2024 · Mar 31, 2024 $5.51M
Total Liabilities Q1 2024 · Dec 31, 2023 $5.48M
Current Assets Q1 2024 · Mar 31, 2024 $1.24M
Current Assets Q1 2024 · Dec 31, 2023 $1.39M
Total Assets Q1 2024 · Mar 31, 2024 $1.49M
Total Assets Q1 2024 · Dec 31, 2023 $1.67M
Shares Diluted restated Q1 2024 · Mar 31, 2023 49.3K sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$499K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$2.86M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$2.88M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.02
Eps Basic Q1 2024 · Mar 31, 2023 −$0.02
Sga Expense Q1 2024 · Mar 31, 2023 $776K
Rd Expense Q1 2024 · Mar 31, 2023 $7K
Net Income Q1 2024 · Mar 31, 2023 −$869K
Operating Income Q1 2024 · Mar 31, 2023 −$843K
Gross Profit Q1 2024 · Mar 31, 2023 $13K
Revenue Q1 2024 · Mar 31, 2023 $22K